Endogenous tissue plasminogen activator and risk of recurrent cardiac events after an acute coronary syndrome in the MIRACL study
Year: 2009
Type: article
Source: Atherosclerosis
Institutions: Brigham and Women's Hospital, Harvard University, VA Boston Healthcare System, Denver VA Medical Center, Linköping University, Boston Children's Hospital, Pfizer (United States), San Francisco General Hospital, University of California, San Francisco, University of California San Francisco Medical Center
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2086729844
